Clinical Trial Update: Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant [NA]

View source ↗

Summary

Clinical trial assessing Lactobacillus rhamnosus GG to reduce graft-versus-host disease in patients after donor stem cell transplantation has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Lactobacillus rhamnosus GG (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Graft Versus Host Disease | NA | Status: COMPLETED | Results posted: 2018-11-16